Compare OVID & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | CTKB |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 541.1M |
| IPO Year | 2017 | 2021 |
| Metric | OVID | CTKB |
|---|---|---|
| Price | $2.64 | $4.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $4.60 | ★ $5.63 |
| AVG Volume (30 Days) | ★ 1.5M | 752.8K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,252,000.00 | ★ $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | $19.34 | $7.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1181.27 | 17.67 |
| 52 Week Low | $0.52 | $3.28 |
| 52 Week High | $3.11 | $6.18 |
| Indicator | OVID | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 38.52 |
| Support Level | $2.56 | $4.13 |
| Resistance Level | $2.77 | $4.49 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 92.78 | 17.83 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.